These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39075289)

  • 1. Off-the-shelf CAR T cells for refractory autoimmunity.
    Papatriantafyllou M
    Nat Rev Rheumatol; 2024 Sep; 20(9):527. PubMed ID: 39075289
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-the-shelf CAR-T cells could prove paradigm shifting for autoimmune diseases.
    Baker DJ; June CH
    Cell; 2024 Sep; 187(18):4826-4828. PubMed ID: 39241743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease.
    Lee AY; Reed JH
    Immunol Cell Biol; 2024 Jul; 102(6):437-440. PubMed ID: 38693765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAR T Cells - A New Horizon for Autoimmunity?
    Isaacs JD
    N Engl J Med; 2024 Feb; 390(8):758-759. PubMed ID: 38381679
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Comte D
    Rev Med Suisse; 2024 Jun; 20(877):1139. PubMed ID: 38836401
    [No Abstract]   [Full Text] [Related]  

  • 6. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
    Ghassemi S; Milone MC
    J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR T-Cell Therapy in Autoimmune Disease. Reply.
    Müller F; Mackensen A; Schett G
    N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
    [No Abstract]   [Full Text] [Related]  

  • 8. CAR T-Cell Therapy in Autoimmune Disease.
    Howard JF; Vu T; Mozaffar T
    N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
    [No Abstract]   [Full Text] [Related]  

  • 9. CAR T cells for infection, autoimmunity and allotransplantation.
    Maldini CR; Ellis GI; Riley JL
    Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR T-Cell Therapy in Autoimmune Disease.
    Merkt W; Lorenz HM; Schmitt M
    N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
    [No Abstract]   [Full Text] [Related]  

  • 11. CAR T-Cell Therapy in Autoimmune Disease.
    De Benedetti F; Diomedi Camassei F; Locatelli F
    N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
    [No Abstract]   [Full Text] [Related]  

  • 12. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
    Zhang PF; Xie D; Li Q
    Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
    Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
    Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
    Daamen AR; Lipsky PE
    Ann Rheum Dis; 2024 May; 83(6):696-699. PubMed ID: 38637134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
    Lyu X; Gupta L; Tholouli E; Chinoy H
    Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontiers in CAR-T cell therapy for autoimmune diseases.
    Li YR; Lyu Z; Chen Y; Fang Y; Yang L
    Trends Pharmacol Sci; 2024 Sep; 45(9):839-857. PubMed ID: 39147651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic CAR T cells for autoimmune diseases: a glimpse into the future.
    Mougiakakos D
    Signal Transduct Target Ther; 2024 Oct; 9(1):276. PubMed ID: 39379353
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
    Morgan MA; Büning H; Sauer M; Schambach A
    Front Immunol; 2020; 11():1965. PubMed ID: 32903482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.